Wedbush Downgrades Idera Pharmaceuticals (IDRA) to Neutral

March 19, 2021 6:54 AM EDT
Get Alerts IDRA Hot Sheet
Price: $1.10 --0%

Rating Summary:
    4 Buy, 4 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 7 | Down: 7 | New: 42
Trade Now! 
Join SI Premium – FREE

Wedbush analyst Robert Driscoll downgraded Idera Pharmaceuticals (NASDAQ: IDRA) from Outperform to Neutral.


For an analyst ratings summary and ratings history on Idera Pharmaceuticals click here. For more ratings news on Idera Pharmaceuticals click here.


Shares of Idera Pharmaceuticals closed at $2.24 yesterday.


You May Also Be Interested In





Related Categories

Downgrades